Ogluo यूरोपीय संघ - स्लोवेनियाई - EMA (European Medicines Agency)

ogluo

tetris pharma b.v - glukagon - sladkorna bolezen - trebušne slinavke hormonov, glycogenolytic hormonov - ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.